1- (2,3-Dichlorophenyl) piperazine Hydrochloride CAS 119532-26-2 Aripiprazole Intermediate Purity>99.0% (HPLC)

Apejuwe kukuru:

Orukọ: 1- (2,3-Dichlorophenyl) piperazine Hydrochloride

Synonyms: 2,3-DCPP HCl

CAS: 119532-26-2

Mimọ:> 99.0% (HPLC)

Irisi: Funfun tabi Paa-White Powder

Agbedemeji ti Aripiprazole (CAS: 129722-12-9)

E-Mail: alvin@ruifuchem.com

Fi imeeli ranṣẹ si wa

Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Olupese Ipese Intermediates ti Aripiprazole Pẹlu Giga Mimo
Aripiprazole API CAS 129722-12-9
1- (2,3-Dichlorophenyl) piperazine Hydrochloride CAS 119532-26-2
7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone CAS 22246-18-0
7- (4-Bromobutoxy) -3,4-Dihydro-2 (1H) - Quinolinone CAS 129722-34-5

Kemikali Properties:

Orukọ Kemikali	1- (2,3-Dichlorophenyl) Piperazine Hydrochloride
Awọn itumọ ọrọ sisọ	2,3-DCPP HCl;1- (2,3-Dichlorophenyl) piperazine HCl;Aripiprazole EP Aimọ B;Aripiprazole Jẹmọ Agbo C
Nọmba CAS	119532-26-2
NỌMBA CAT	RF-PI2268
Iṣura Ipo	Ni Iṣura, Agbara iṣelọpọ 30 MT / osù
Ilana molikula	C10H12Cl2N2 · HCl
Òṣuwọn Molikula	267.58
Ojuami Iyo	245.0 ~ 247.0 ℃
Ibi ipamọ & Ifamọ	Hygroscopic.Awọn iwọn otutu ibaramu
Solubility ninu Omi	Tiotuka ninu Omi
Brand	Ruifu Kemikali

Awọn pato:

Nkan	Awọn pato
Ifarahan	Funfun tabi Pa-White Powder
Mimọ / Analysis Ọna	> 99.0% (HPLC)
Pipadanu lori Gbigbe	<0.50%
Aloku lori Iginisonu	<0.10%
Aimọ Kanṣoṣo	<0.50%
Lapapọ Awọn Aimọ	<1.00%
Awọn irin Heavy (gẹgẹbi Pb)	≤20ppm
Infurarẹẹdi julọ.Oniranran	Ni ibamu si Eto
Igbeyewo Standard	Standard Enterprise
Lilo	Agbedemeji ti Aripiprazole (CAS: 129722-12-9)

Package & Ibi ipamọ:

Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara

Ipò Ìpamọ́:Hygroscopic.Tọju kuro lati omi / ọrinrin ati awọn aṣoju oxidizing.Jeki apo eiyan naa ni wiwọ ki o si gbe e si ibi ti o tutu, gbẹ ati ipo atẹgun daradara.Itaja labẹ inert gaasi

Awọn anfani:

FAQ:

Ohun elo:

1- (2,3-Dichlorophenyl) piperazine Hydrochloride (CAS: 119532-26-2) jẹ agbedemeji pataki ti Aripiprazole (CAS: 129722-12-9).Aripiprazole jẹ iru tuntun ti awọn itọsẹ quinoline ti o ni ọra ti o ga pupọ, awọn ipa elegbogi rẹ ti iwa ni pe kii ṣe awọn antagonist olugba postsynaptic dopamine D 2 nikan, ṣugbọn tun presynaptic dopamine D 2 agonist olugba, o tun le ṣe itara D 1, D 3, D 4 awọn olugba;o ni ipa meji ti imuṣiṣẹ apakan tabi antagonistic olugba lori olugba 5-HT 1A;o ni igbese atako patapata lori olugba 5-HT 2A.Ẹya yii yatọ si iran akọkọ, ati awọn antipsychotics atypical eyiti o jẹ ti awọn oogun antipsychotic iran-keji, ati nitorinaa o jẹ amuduro eto dopamine tabi antipsychotic iran kẹta.Niwọn igba ti o ti n ta ni ọja, o jẹ lilo akọkọ ni schizophrenia ile-iwosan, itọju awọn rudurudu ti o ni ipa ati awọn rudurudu ọpọlọ miiran.Gẹgẹbi awọn iwe-iwe, aripiprazole ni awọn ipa pataki lori schizophrenia rere ati awọn aami aiṣan ti ko dara ati aibalẹ, ibanujẹ, iṣẹ iṣaro, lakoko ti ailewu ti o ga julọ.O tun royin pe oogun naa tun le ṣe itọju awọn rudurudu ọpọlọ miiran, gẹgẹbi awọn rudurudu iṣesi awọn iṣẹlẹ manic, iyawere agbalagba ti o ni nkan ṣe pẹlu awọn rudurudu ọpọlọ, awọn rudurudu aibalẹ, awọn rudurudu ihuwasi awọn ọmọde, ibanujẹ.Lasiko yi, Bristol-Myers Squibb ati Otsuka Pharmaceutical Company kede pe European Union ti fọwọsi Abilify (aripiprazole) ni itọju ohun elo atokọ schizophrenia.